<VariationArchive VariationID="1676673" VariationName="NM_017446.4(MRPL39):c.526del (p.Ser176fs)" VariationType="Deletion" Accession="VCV001676673" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2022-10-08" MostRecentSubmission="2023-12-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1668250" VariationID="1676673">
      <GeneList>
        <Gene Symbol="MRPL39" FullName="mitochondrial ribosomal protein L39" GeneID="54148" HGNC_ID="HGNC:14027" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="25585656" stop="25607859" display_start="25585656" display_stop="25607859" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="26957967" stop="26979800" display_start="26957967" display_stop="26979800" Strand="-" />
          </Location>
          <OMIM>611845</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_017446.4(MRPL39):c.526del (p.Ser176fs)</Name>
      <CanonicalSPDI>NC_000021.9:25599860:AAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="25599861" stop="25599861" display_start="25599861" display_stop="25599861" variantLength="1" positionVCF="25599860" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="26972173" stop="26972173" display_start="26972173" display_stop="26972173" variantLength="1" positionVCF="26972172" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>S176fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.26972175del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.26972175del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.25599863del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.25599863del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017446.4" sequenceAccession="NM_017446" sequenceVersion="4" change="c.526del" MANESelect="true">
            <Expression>NM_017446.4:c.526del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_059142.3" sequenceAccession="NP_059142" sequenceVersion="3" change="p.Ser176fs">
            <Expression>NP_059142.3:p.Ser176fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080794.4" sequenceAccession="NM_080794" sequenceVersion="4" change="c.526del">
            <Expression>NM_080794.4:c.526del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_542984.3" sequenceAccession="NP_542984" sequenceVersion="3" change="p.Ser176fs">
            <Expression>NP_542984.3:p.Ser176fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017446.4" sequenceAccession="NM_017446" sequenceVersion="4" change="c.526delT" MANESelect="true">
            <Expression>NM_017446.4:c.526delT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="611845.0003" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017446.4(MRPL39):c.526del (p.Ser176fs) AND Leigh syndrome" Accession="RCV002286588" Version="2">
        <ClassifiedConditionList TraitSetID="2407">
          <ClassifiedCondition DB="MedGen" ID="C0023264">Leigh syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-24" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_017446.4(MRPL39):c.526del (p.Ser176fs) AND Combined oxidative phosphorylation deficiency 59" Accession="RCV003445148" Version="1">
        <ClassifiedConditionList TraitSetID="92335">
          <ClassifiedCondition DB="MedGen" ID="C5882730">Combined oxidative phosphorylation deficiency 59</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-12-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-24" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-10-08" MostRecentSubmission="2023-12-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">37133451</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-24">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="2407" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5390" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Leigh Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leigh syndrome</ElementValue>
                <XRef ID="MONDO:0009723" DB="MONDO" />
                <XRef ID="506" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Subacute necrotizing encephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Necrotizing encephalopathy infantile subacute of Leigh</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh's necrotizing encephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh's disease</ElementValue>
                <XRef ID="Leigh+syndrome/4157" DB="Genetic Alliance" />
                <XRef ID="29570005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEIGH SYNDROME, NUCLEAR</ElementValue>
                <XRef Type="MIM" ID="256000" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NULS</ElementValue>
                <XRef Type="MIM" ID="256000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SNE</ElementValue>
                <XRef Type="MIM" ID="256000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6877" />
                <XRef ID="6877" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301352</ID>
                <ID Source="BookShelf">NBK1173</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301382</ID>
                <ID Source="BookShelf">NBK1203</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301403</ID>
                <ID Source="BookShelf">NBK1224</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26425749</ID>
                <ID Source="BookShelf">NBK320989</ID>
              </Citation>
              <Citation Type="general" Abbrev="MMS, 2017">
                <ID Source="PubMed">28749475</ID>
                <ID Source="pmc">7804217</ID>
              </Citation>
              <XRef ID="506" DB="Orphanet" />
              <XRef ID="C0023264" DB="MedGen" />
              <XRef ID="MONDO:0009723" DB="MONDO" />
              <XRef Type="MIM" ID="256000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="92335" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="72347" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Combined oxidative phosphorylation deficiency 59</ElementValue>
                <XRef ID="MONDO:0957992" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">COXPD59</ElementValue>
                <XRef Type="MIM" ID="620646" DB="OMIM" />
              </Symbol>
              <XRef ID="C5882730" DB="MedGen" />
              <XRef ID="MONDO:0957992" DB="MONDO" />
              <XRef Type="MIM" ID="620646" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4889205" SubmissionDate="2022-04-04" DateLastUpdated="2022-10-08" DateCreated="2022-10-08">
        <ClinVarSubmissionID localKey="L39indel" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002499441" DateUpdated="2022-10-08" DateCreated="2022-10-08" Type="SCV" Version="1" SubmitterName="Mitochondrial Research Group, Murdoch Children's Research Institute" OrgID="506250" OrganizationCategory="laboratory" OrgAbbreviation="MITORES_MCRI" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <TypePlatform>Exome sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <CellLine>Primary fibroblasts</CellLine>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>exome sequencing</TypePlatform>
              <Purpose>assert pathogenicity</Purpose>
              <Description>Western blotting, RNAseq, quantitative proteomics, cDNA studies</Description>
              <MethodType>research</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">This change c.526delT creates a premature stop-codon and undergoes NMD as determined by both cDNA studies and RNAseq studies. For the cDNA studies, RNA was derived from patient fibroblasts grown with or without cycloheximide (CHX) to inhibit NMD, transcripts containing the c.526delT variant were only detected in the presence of CHX. MRPL39 protein levels were reduced in patient fibroblasts and resulted in destabilisation of the mitoribosomal large subunit as detected by both western blotting and quantitative proteomics as well as a decrease in mitochondrial oxidative phosphorylation (OXPHOS) complexes I, III, IV and V (which contain mitochondrially DNA encoded subunits and require the mitoribosome for translation).</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MRPL39" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="746607851" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017446.4:c.526delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11291265</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5414103" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_017446_3_MRPL39_c_526delT" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002768366" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely Pathogenic. Following criteria are met: 0102 - Loss of function is a suggested mechanism of disease in this gene and is associated with lethal infantile mitochondrial disease. (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD &lt;0.01 for a recessive condition (v2: 30 heterozygotes, 0 homozygotes). (SP) 0402 - Variant is located in a gene associated with a severe early-onset recessive condition that is intolerant to bi-allelic loss of function variants (gnomAD). (SP) 0703 - Other NMD-predicted variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1001 - This variant has strong functional evidence supporting abnormal protein function. Western blots on patient fibroblasts showed destabilisation of the mitoribosome and defective translation of the OXPHOS complexes. (SP) 1206 - This variant has been shown to be paternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MRPL39" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6715</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017446.3:c.526delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009723" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7809865" SubmissionDate="2023-12-04" DateLastUpdated="2023-12-09" DateCreated="2023-12-09">
        <ClinVarSubmissionID localKey="611845.0003_COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59" title="MRPL39, 1-BP DEL, 526T (rs746607851)_COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59" />
        <ClinVarAccession Accession="SCV004174177" DateUpdated="2023-12-09" DateCreated="2023-12-09" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp deletion (c.526delT, NM_017446.4) in the MRPL39 gene, predicted to result in a frameshift and premature termination (Ser176LeufsTer8), that was identified in compound heterozygous state in a patient (patient 2) with combined oxidative phosphorylation deficiency-59 (COXPD59; 620646) by Amarasekera et al. (2023), see 611845.0001.</Attribute>
              <Citation>
                <ID Source="PubMed">37133451</ID>
              </Citation>
              <XRef DB="OMIM" ID="620646" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MRPL39" />
          </GeneList>
          <Name>MRPL39, 1-BP DEL, 526T (rs746607851)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 526T (rs746607851)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611845.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7809865" TraitType="Disease" MappingType="Name" MappingValue="COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59" MappingRef="Preferred">
        <MedGen CUI="C5882730" Name="Combined oxidative phosphorylation deficiency 59" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5414103" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009723" MappingRef="MONDO">
        <MedGen CUI="C0023264" Name="Leigh syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4889205" TraitType="Disease" MappingType="XRef" MappingValue="256000" MappingRef="OMIM">
        <MedGen CUI="C0023264" Name="Leigh syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

